- Nachrichtendetail
-
06.03.2024 15:07:00 - dpa-AFX: *J&J SEEKS EMA APPROVAL FOR DARZALEX QUADRUPLET THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Frankfurt | 137,000 | 26.04.24 20:39:57 | -0,500 | -0,36% | 0,000 | 0,000 | 137,900 | 137,000 |
